Showing results (1-10 of 760) with videos related to
Sort By:
Pageof 76
Revue Medicale De Liege|December 9, 2022
[Inclisiran (Leqvio®), a potent cholesterol-lowering agent by inhibiting PCSK9 using small interfering RNA-based innovative therapy]A J Scheen, C Wallemacq, P LancellottiRevue Medicale De Liege|April 9, 2020
[Ezetimibe-rosuvastatin fixed-dose combination (Myrosor®)]C Wallemacq, A J ScheenRevue Medicale De Liege|February 26, 2014
[European guidelines for the management of diabetes, prediabetes and cardiovascular disease. Second part. Managemnet of cardiac, cerebrovascular and peripheral artery complications]A J Scheen, P LancellottiRevue Medicale De Liege|April 8, 2021
[SGLT2 inhibitors, new option to prevent or treat heart failure]A J Scheen, P LancellottiRevue Medicale De Liege|December 7, 2010
[Medication of the month. Dabigatran etixilate (Pradaxa): an oral anticoagulant acting as a direct selective inhibitor of thrombin]P Lancellotti, A J ScheenRevue Medicale De Liege|April 8, 2017
[Edoxaban (LIXIANA®) : new oral anticoagulant forthetreatment and secondary prevention of thromboembolic disease]A J Scheen, P LancellottiRevue Medicale De Liege|February 10, 2022
[Bempedoïc acid, new cholesterol-lowering drug]A J Scheen, N Paquot, C WallemacqRevue Medicale De Liege|February 5, 2021
[Fixed combination atorvastatin-perindopril (Lipercosyl®) for substitution treatment of cardiovascular risk management]P Lancellotti, A Ancion, A J ScheenRevue Medicale De Liege|February 5, 2021
[Anticoagulation of diabetic patients with nonvalvular atrial fibrillation]A J Scheen, M Sprynger, P LancellottiRevue Medicale De Liege|June 22, 2018
[Syncope in the emergencry room: Differential diagnosis and risk stratification]P Marechal, A J Scheen, P LancellottiPageof 76